Page 64 - GPD-3-2

Gene & Protein in Disease TOPK: Target for lung cancer treatment

Consent for publication Phosphorylation of IκBα at serine 32 by T-lymphokine-
activated killer cell-originated protein kinase is essential
Not applicable. for chemoresistance against doxorubicin in cervical cancer
Availability of data cells. J Biol Chem. 2013;288(5):3585-3593.
doi: 10.1074/jbc.M112.422170
Not applicable.
11. Huang H, Lee MH, Liu K, Dong Z, Ryoo Z, Kim MO. PBK/
References TOPK: An effective drug target with diverse therapeutic
potential. Cancers (Basel). 2021;13(9):2232.
1. Ishikawa C, Senba M, Mori N. Mitotic kinase PBK/TOPK as
a therapeutic target for adult Tcell leukemia/lymphoma. Int doi: 10.3390/cancers13092232
J Oncol. 2018;53(2):801-814. 12. Zhang L, Wang F, Yi H, et al. The role of T-LAK cell-
doi: 10.3892/ijo.2018.4427 originated protein kinase in targeted cancer therapy. Mol
2. Gaudet S, Branton D, Lue RA. Characterization of PDZ- Cell Biochem. 2022;477(3):759-769.
binding kinase, a mitotic kinase. Proc Natl Acad Sci U S A. doi: 10.1007/s11010-021-04329-5
2000;97(10):5167-5172.
13. Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence,
doi: 10.1073/pnas.090102397 mortality, years of life lost, years lived with disability, and
3. Sun H, Zheng J, Xiao J, et al. TOPK/PBK is phosphorylated disability-adjusted life years for 29 Cancer groups from
by ERK2 at serine 32, promotes tumorigenesis and is 2010 to 2019: A systematic analysis for the global burden of
involved in sorafenib resistance in RCC. Cell Death Dis. disease study 2019. JAMA Oncol. 2022;8(3):420-444.
2022;13(5):450. doi: 10.1001/jamaoncol.2021.6987
doi: 10.1038/s41419-022-04909-3
14. Raskova Kafkova L, Mierzwicka JM, Chakraborty P, et al.
4. Zykova TA, Zhu F, Wang L, et al. The T-LAK cell-originated NSCLC: From tumorigenesis, immune checkpoint misuse
protein kinase signal pathway promotes colorectal cancer to current and future targeted therapy. Front Immunol.
metastasis. EBioMedicine. 2017;18:73-82. 2024;15:1342086.
doi: 10.1016/j.ebiom.2017.04.003 doi: 10.3389/fimmu.2024.1342086
5. Li Y, Yang Z, Li W, et al. TOPK promotes lung cancer resistance 15. Dougherty JD, Garcia AD, Nakano I, et al. PBK/TOPK, a
to EGFR tyrosine kinase inhibitors by phosphorylating and proliferating neural progenitor-specific mitogen-activated
activating c-Jun. Oncotarget. 2016;7(6):6748-6764. protein kinase kinase. J Neurosci. 2005;25(46):10773-10785.
doi: 10.18632/oncotarget.6826 doi: 10.1523/jneurosci.3207-05.2005
6. Xue P, Wang Y, Zeng F, et al. Paeonol suppresses solar ultraviolet- 16. Zhu F, Zykova TA, Kang BS, et al. Bidirectional signals
induced skin inflammation by targeting T-LAK cell-originated transduced by TOPK-ERK interaction increase
protein kinase. Oncotarget. 2017;8(16):27093-27104. tumorigenesis of HCT116 colorectal cancer cells.
Gastroenterology. 2007;133(1):219-231.
doi: 10.18632/oncotarget.15636
doi: 10.1053/j.gastro.2007.04.048
7. Zykova TA, Zhu F, Lu C, et al. Lymphokine-activated killer
T-cell-originated protein kinase phosphorylation of histone 17. Xiao J, Zhang L, Yi H, et al. Inhibiting ALK-TOPK signaling
H2AX prevents arsenite-induced apoptosis in RPMI7951 pathway promotes cell apoptosis of ALK-positive NSCLC.
melanoma cells. Clin Cancer Res. 2006;12(23):6884-6893. Cell Death Dis. 2022;13(9):828.
doi: 10.1158/1078-0432.Ccr-06-0410 doi: 10.1038/s41419-022-05260-3
8. Zykova TA, Zhu F, Vakorina TI, et al. T-LAK cell-originated 18. Park JH, Inoue H, Kato T, et al. TOPK (T-LAK cell-originated
protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 protein kinase) inhibitor exhibits growth suppressive effect
prevents UVB-induced apoptosis in RPMI7951 melanoma on small cell lung cancer. Cancer Sci. 2017;108(3):488-496.
cells through the regulation of Prx1 peroxidase activity. doi: 10.1111/cas.13160
J Biol Chem. 2010;285(38):29138-29146.
19. Cai C, Yao S, Zou Y, et al. KRAS(G12C) mutation-
doi: 10.1074/jbc.M110.135905
induced TOPK overexpression contributes to tumour
9. Lu H, Xiao J, Ke C, et al. TOPK inhibits autophagy by progression in non-small cell lung cancer. J Cell Mol Med.
phosphorylating ULK1 and promotes glioma resistance to 2023;27(12):1637-1652.
TMZ. Cell Death Dis. 2019;10(8):583.
doi: 10.1111/jcmm.17640
doi: 10.1038/s41419-019-1805-9
20. Shih MC, Chen JY, Wu YC, et al. TOPK/PBK promotes cell
10. Park JH, Yoon DS, Choi HJ, Hahm DH, Oh SM. migration via modulation of the PI3K/PTEN/AKT pathway

Volume 3 Issue 2 (2024) 8 doi: 10.36922/gpd.3062